Literature DB >> 2350783

TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences.

T Kanzaki1, A Olofsson, A Morén, C Wernstedt, U Hellman, K Miyazono, L Claesson-Welsh, C H Heldin.   

Abstract

TGF-beta occurs in a latent complex of high Mr. We report the cDNA cloning and an initial structural and functional characterization of a component of the large latent TGF-beta 1 complex, denoted TGF-beta 1 binding protein (TGF-beta 1-BP). Most of the sequence of fibroblast TGF-beta 1-BP is made up of cysteine-rich repeats of two different kinds; there are 16 EGF-like repeats and three repeats with a distant resemblance to EGF, but of a distinct type hitherto not found in any other protein. beta-hydroxylated asparagine residues were identified in two of the EGF-like repeats. TGF-beta 1-BP purified from human platelets is considerably smaller than the fibroblast form (125-160 kd vs. 170-190 kd), suggesting that there is alternative splicing of the TGF-beta 1-BP gene or that TGF-beta 1-BP undergoes cell-specific proteolysis. TGF-beta 1-BP was found not to bind and inactive TGF-beta 1; its role in the latent complex is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350783     DOI: 10.1016/0092-8674(90)90069-q

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  93 in total

1.  N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: a possible first step in microfibril assembly.

Authors:  T M Trask; T M Ritty; T Broekelmann; C Tisdale; R P Mecham
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

2.  Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.

Authors:  L V Clark; M Buckland; G Murphy; N Taylor; V Vleck; C Mein; E Wozniak; M Smuk; P D White
Journal:  Clin Exp Immunol       Date:  2017-10-11       Impact factor: 4.330

3.  Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta.

Authors:  J Saharinen; J Keski-Oja
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

Review 4.  The extracellular regulation of growth factor action.

Authors:  R Flaumenhaft; D B Rifkin
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

Review 5.  TGF-beta: problems and prospects.

Authors:  M B Sporn; A B Roberts
Journal:  Cell Regul       Date:  1990-11

Review 6.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

7.  Novel functional single nucleotide polymorphisms in the latent transforming growth factor-beta binding protein-1L promoter: effect on latent transforming growth factor-beta binding protein-1L expression level and possible prognostic significance in ovarian cancer.

Authors:  Tomomi Higashi; Satoru Kyo; Masaki Inoue; Hideji Tanii; Kiyofumi Saijoh
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

Review 8.  LTBPs in biology and medicine: LTBP diseases.

Authors:  Daniel B Rifkin; William J Rifkin; Lior Zilberberg
Journal:  Matrix Biol       Date:  2017-12-05       Impact factor: 11.583

9.  Purification and partial amino acid sequence of suppressive lymphokine from a CD8+ CD57+ human T hybridoma.

Authors:  C P Quan; S Watanabe; F Vuillier; R Pires; T Matsuo; M Stanislawski; J Pillot; J P Bouvet
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

Review 10.  Identification of defects in the fibrillin gene and protein in individuals with the Marfan syndrome and related disorders.

Authors:  D M Milewicz
Journal:  Tex Heart Inst J       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.